Steven Cohen Genmab A/S Transaction History

Point72 Asset Management, L.P.

$36 Billion
Q2 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Genmab A/S stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 18,184 shares of GMAB stock, worth $420,232. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,184

Previous 18,184 -0.0%

Holding current value

$420,232

Previous $456,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.13 - $30.27 $456,963 - $550,429	18,184 New	18,184 $456,000
Q4 2023 Feb 14, 2024	SELL	$27.94 - $35.44 $4.96 Million - $6.29 Million	-177,501 Reduced 63.71%	101,100 $3.22 Million
Q3 2023 Nov 14, 2023	BUY	$35.27 - $42.24 $3.57 Million - $4.27 Million	101,101 Added 56.96%	278,601 $9.83 Million
Q2 2023 Aug 14, 2023	SELL	$37.4 - $42.94 $3.11 Million - $3.58 Million	-83,266 Reduced 31.93%	177,500 $6.75 Million
Q1 2023 May 15, 2023	BUY	$34.88 - $43.22 $9.1 Million - $11.3 Million	260,766 New	260,766 $9.85 Million
Q4 2021 Feb 14, 2022	SELL	$35.87 - $47.12 $2.03 Million - $2.67 Million	-56,600 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$41.55 - $48.72 $16 Million - $18.8 Million	-385,000 Reduced 87.18%	56,600 $2.47 Million
Q2 2021 Aug 16, 2021	BUY	$32.88 - $44.57 $7 Million - $9.49 Million	212,900 Added 93.09%	441,600 $18 Million
Q1 2021 May 17, 2021	BUY	$30.92 - $44.4 $7.07 Million - $10.2 Million	228,700 New	228,700 $7.51 Million

Others Institutions Holding GMAB

# of Institutions

235

Shares Held

48.7M

Call Options Held

6.8K

Put Options Held

27.6K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $15.2B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account